Regional but fatal: Intraperitoneal metastasis in gastric cancer.
Peritoneal carcinomatosis appears to be the most common pattern of metastasis or recurrence and is associated with poor prognosis in gastric cancer patients. Many efforts have been made to improve the survival in patients with peritoneal metastasis. Hyperthermic intraperitoneal chemotherapy remains a widely accepted strategy in the treatment of peritoneal dissemination. Several phase II-III studies confirmed that the combined cytoreducitve surgery and hyperthermic intraperitoneal chemotherapy resulted in longer survival in patients with peritoneal carcinomatosis. In addition, proper selection and effective regional treatment in patients with high risk of peritoneal recurrence after resection will further improve prognosis in local advanced gastric cancer patients.
Jia Wei, Nan-Die Wu, Bao-Rui Liu, Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing 210008, Jiangsu Province, China.
Jia
J
Wei
Jia Wei, Nan-Die Wu, Bao-Rui Liu, Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing 210008, Jiangsu Province, China.
Nan-Die
ND
Wu
Jia Wei, Nan-Die Wu, Bao-Rui Liu, Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing 210008, Jiangsu Province, China.
Bao-Rui
BR
Liu
D000970:Antineoplastic Agents / Q000627:therapeutic use; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000379:methods*; D002986:Clinical Trials as Topic; D006801:Humans; D006979:Hyperthermia, Induced; D009364:Neoplasm Recurrence, Local; D010534:Peritoneal Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality / Q000556:secondary*; D011379:Prognosis; D013274:Stomach Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality / Q000473:pathology*; D016896:Treatment Outcome
D000970:Antineoplastic Agents
Cytoreductive surgery; Gastric cancer; Hyperthermic intraperitoneal chemotherapy; Intraperitoneal metastasis; Regional metastasis
J Am Coll Surg. 2006 Feb;202(2):231-6
16427547
Eur J Cancer. 2009 Apr;45(6):931-91
19171476
Cancer Chemother Pharmacol. 2013 May;71(5):1265-72
23423490
Ann Oncol. 2010 Jan;21(1):67-70
19605503
Gastric Cancer. 2000 Sep 29;3(2):63-70
11984713
Ann Surg Oncol. 2015 Mar;22(3):758-64
25201501
Diagn Mol Pathol. 2003 Jun;12(2):88-95
12766613
Gastric Cancer. 2012 Sep;15 Suppl 1:S27-37
21809111
Clin Cancer Res. 2012 May 1;18(9):2668-78
22421191
Ann Surg Oncol. 2015 Sep;22(9):2940-7
25605515
Int J Hyperthermia. 2012;28(6):509-17
22834701
J Control Release. 2015 Feb 28;200:188-200
25553823
J Gastric Cancer. 2014 Mar;14(1):23-31
24765534
World J Surg. 2006 Nov;30(11):2033-40; discussion 2041-2
17006608
Br J Cancer. 2008 Jan 29;98(2):512-3; author reply 514
18195708
Biochem Soc Trans. 1990 Dec;18(6):1214
2088875
J Surg Oncol. 2015 Feb;111(2):248
25279726
Oncol Rep. 2006 Aug;16(2):361-6
16820916
Dig Surg. 2010;27(6):481-6
21063125
Genet Mol Res. 2012 Jun 25;11(2):1682-9
22782588
Transl Oncol. 2013 Dec 01;6(6):784-93
24466382
Ann Surg Oncol. 2010 Dec;17(12):3077-9
20882416
Ann Surg Oncol. 2005 May;12(5):347-53
15915368
Jpn J Clin Oncol. 2013 Nov;43(11):1157-8
24186939
Ann Surg Oncol. 2010 Sep;17(9):2370-7
20336386
World J Gastrointest Oncol. 2010 Feb 15;2(2):85-97
21160926
J Cancer Res Clin Oncol. 1996;122(10):590-5
8879256
Gastric Cancer. 2013 Jan;16(1):48-55
22362376
J Surg Oncol. 2008 Sep 15;98(4):273-6
18726891
Crit Rev Oncol Hematol. 2002 Jul;43(1):33-56
12098606
Gastric Cancer. 2007;10(4):197-204
18095074
Arch Pathol Lab Med. 2014 Nov;138(11):1466-73
25357107
Eur J Surg Oncol. 2010 Dec;36(12):1131-8
20933363
Lancet Oncol. 2003 May;4(5):277-83
12732164
Surg Today. 2003;33(11):839-46
14605956
Gastric Cancer. 2015 Jan;18(1):11-22
24890254
Oncogene. 2011 Nov 3;30(44):4498-508
21602894
Cancer. 1999 Feb 1;85(3):529-34
10091726
Ann Surg. 2004 Nov;240(5):808-16
15492562
Medicine (Baltimore). 2014 Sep;93(11):e83
25192488
Ann Surg Oncol. 2010 Feb;17(2):448-54
19904573
J Clin Oncol. 1994 May;12(5):970-4
8164049
Asia Pac J Clin Oncol. 2013 Dec;9(4):324-30
23176400
Gan To Kagaku Ryoho. 2004 Nov;31(12):2031-4
15570934
Gastric Cancer. 2012 Sep;15 Suppl 1:S38-47
21667136
Ann Surg Oncol. 2007 Oct;14(10):2702-13
17653801
Int J Cancer. 2010 Nov 1;127(9):2209-21
20473913
Br J Cancer. 2002 Nov 4;87(10):1153-61
12402156
Biomed Pharmacother. 2015 Apr;71:240-6
25960243
Ann Surg Oncol. 2015 Jul;22(7):2336-42
25404476
Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5896-901
14676112
Ann Surg Oncol. 2002 May;9(4):394-400
11986192
J Surg Oncol. 2015 Jun;111(8):1041-6
26060133
Br J Surg. 2000 Feb;87(2):236-42
10671934
Cancer Invest. 2012 Mar;30(3):209-24
22360361
Cancer Res. 1980 Feb;40(2):253-5
7356508
Exp Ther Med. 2012 Sep;4(3):355-362
23181099
Br J Surg. 2011 Sep;98(9):1225-35
21644239
Radiother Oncol. 2012 Sep;104(3):367-73
22981610
Eur J Pharmacol. 2012 Jan 15;674(2-3):143-52
22119383
Oncology. 1993 Sep-Oct;50(5):338-43
8378028
Int J Surg Oncol. 2014;2014:912418
24693422
Onkologie. 2011;34(3):101-8
21358214
J Surg Oncol. 2010 Jun 1;101(7):637-42
20461774
Mol Clin Oncol. 2015 Mar;3(2):435-441
25798282
Surg Oncol Clin N Am. 2012 Oct;21(4):625-33
23021720
Surg Today. 2011 Feb;41(2):210-5
21264756
J Oncol Pharm Pract. 2005 Sep;11(3):111-9
16390599
J Surg Oncol. 2012 Jan;105(1):38-42
21882194
Anticancer Drugs. 2015 Feb;26(2):123-38
25406023
BMC Surg. 2014 May 16;14:29
24886548
J Surg Oncol. 2014 Sep;110(3):291-7
24850538